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A cDNA encodmg a small GTP-binding protein, SlO, was cloned from Jurkat cells. The deduced amino acid sequence of SIO had the structural 
features characteristic to thts family of protems with highest homology to rab subfamily. Northern blot analysis revealed that this gene is expressed 
only m lymphoid cell lines and a htsttocytic leukemia, U937. Hence, it should have a speciahzed function in cells derived from the hematopoietic 
stem cell. 
GTP-bmdmg protem; Lymphocyte, Macrophage; Vesicular transport 
1. INTRODUCTION 2.2. RNA e.ytractlofl and PCR 
Small GTP-binding proteins are involved in a wide 
variety of cellular functions [l-3], including signal 
transduction (ras) [4], vesicular transport (rab) [5]. con- 
trol of actin cytoskeleton (rho and rat) [6,7], and regula- 
tion of chromatin structure (TC4/ran) [8]. More than 50 
members of small GTP-binding proteins have been re- 
ported so far. Many of them are expressed ubiquitously, 
while some are expressed in tissue-specific manners. Tis- 
sue-specific expression of a protein may represent the 
specificity of the funcitonal role it plays, as suggested 
for rab3A [9] or rac2 [lO,l l] protein. In an attempt to 
isolate small GTP-binding proteins expressed mainly in 
T lymphocytes, we employed polymerase chain reaction 
(PCR) method, which was successfully used to isolate 
new members of this family from marine ray [12]. Here 
we report the cloning of a cDNA which encodes a new 
member of the small GTP-binding proteins from a 
human T lymphocyte cell line, Jurkat. Expression of 
this gene was restricted to cells of lymphoid and mono- 
cytic lineage. 
2. MATERIALS AND METHODS 
2.1 Cell culture 
Cell lines of human origm were cultured in either RPM11640 (for 
cells of hematopoietic origin) or Dulbecco’s modified Eagle’s medium 
(for others) supplemented with 10% fetal bovine serum. 
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Total cellular RNA from cultured cells were extracted as described 
[13] Poly(A)’ RNA was prepared by two passages through an 
ohgo(cellulose column. One pg of poly(A)’ RNA from Jurkat 
cells was used as a template for ohgo(primed cDNA synthesis by 
Superscript reverse transcriptase (BRL) One-hundredth of this reac- 
tion was subJected to PCR to amplify a region of small GTP-binding 
proteins. Two degenerate primers were used m this reaction, 
5’CCCGAATTCTGGGA(TC)ACNGCNGGNCA(GA)GA3’ and 
SGCCGGATCCNA(GA)(GA)TC(GA)CA(TC)TT(GA)TTNCC3’. 
each corresponding to the conserved amino acid sequences of G-3 and 
G-4 [14.15]. respecttvely. The conditions for the PCR were 1 min at 
94°C. 1.5 min at 50°C. and 2 min at 72°C. 
2.3 Clonrng in plasnud and nucleottde sequencmg 
PCR products were separated by agarose gel electrophorests and a 
major band of expected size was recovered. After digestion with EcoRI 
and BarnHI. fragments were subcloned in pBluescript vector (Stra- 
tagene). Double stranded plasmid DNA was sequenced by the dtdeoxy 
chain termination method with Sequenase (United States Biochemi- 
cals) and [a-“P]dCTP (New England Nuclear). 
2.4. Screening of Jurkut cDNA librar) 
Jurkat cDNA library m 1gtlO vector was purchased from Clone- 
tech. About 1 x lo6 plaques were screened with nick translated Insert 
DNA from a PCR clone. SlO. Positive phage clones (SlO-32 and 
SlO-4) were purified and the cDNA inserts subcloned in pBluescript 
were sequenced. 
2.5. Northern blot hybridl-_atzon 
Twenty ,ug each of total RNA was separated by 1.0% agarose gel 
electrophoresis in 6% formaldehyde and transferred to a nitrocellulose 
membrane (Schleicher & Schuell). SlO-4 cDNA was labeled by Mega- 
prime DNA labehng system (Amersham) and used as a probe for SlO. 
Final washing condition was 0.1 x SSC. 0.1% SDS at 50°C. After 
hybridization with SlO probe. membranes were washed twice in 2.5 
mM Tris-HCI, pH 8.0,O.l mM EDTA. 0 025% sodium pyrophosphate 
and 0.05 x Denhardt’s solution, at 70°C for 1 h. and then rehybridized 
with a p-actm probe. 
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3. RESULTS AND DISCUSSION 
3.1. PCR ampl$cation of cI region hetwcen G-3 und G-4 
of’ smrtll GTP-bhding protrim 
Small GTP-binding proteins have regions of con- 
served amino acid sequences (G-l through G-5) which 
are involved in GTP/GDP-binding and GTPasc activity 
[14]. A region between G-3 and G-4 was amplified from 
single-stranded cDNA synthesized from Jurkat 
poly(A)’ RNA using two degenerate oligonucleotides: 
a sense oligonucleotide correspondmg to the amino acid 
sequence WDTAGQE of G-3 and an anti-sense oiigo- 
nucleotide corresponding to GNKCDL of G-4. Nu- 
cleotide sequence were determined for inserts of more 
than 30 PCR clones. Most of them contained sequences 
of previously reported small GTP-binding proteins, in- 
cluding rabl, rab9, TC4lran. and rab13. Two clones 
shared the same sequence which did not correspond to 
any known small GTP-binding proteins. This sequence 
was referred to as SlO. 
3.2. Isolatiorl of (DNA rk~tw.r from u Iibruq’ md se- 
yuetlcr ccnalj~sis 
A Jurkat cell cDNA library was screened with the 
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GGGCCGAGGCGCGGCGGCGGCTGGAGCAGCAGCGCGGTAGGGTCCTTCGCCAGAGCATCCGGT 
GGTTCGGTCCGGGGGAGATGGCGCRGCCCATCCTGGGCCTGGGCCATGG~AGCCTGCAGC~~GC~T 
MA Q P I LGHGSLQ PAS 
CGGCCGCTGGCCTGGCGTCCCTGGAGCTCGACTCGTCGCTGGACCAGTACGTGCAGATT~ 
A AGLASLELD SSLDQYVQIR 
GCATCTTCARAATAATCGTGATTGGGGACTCCAACGTGGGCAAGACCTGCCCGACCTTCC 
I FKIIVI GDSNVGKTCPTFR 
GCTTCTGCGGGGGTACCTTCCCAGACAAGACTGAAGCCACCATCGGCGTGGACT'rCAGGG 
F CGGTFP DKTEATI G V&JR E 
AGAAGACCGTGGAAATCGAGGGCGAGAAGATCAAGGTTCAGGTGTGGGACACAGCAGGTC 
KTVEIE G E K I K V_g V W !I T A G Q 
AGGAACGTTTCCGCAAAAGCATGGTCGAGCATTACTACCGCAACGTACAT~CCGTGGTCT 
E R F R K S M V E H Y Y R N VHAVVF 
TCGTCTATGACGTCACCAAGATGACATCTTTCTTTCACCAACCTCAAAATGTGGAT~CAAGAAT 
v Y DVTKMTS FTNLKMW I Q E C 
GCAATGGGCATGCTGTGCCCCCACTAGTCCCCAAAGTGCTTGTGGGCAA~AAGTGTGACT 
NGHAVPPLVP Kv LV G N K C D L 
TGAGGGAACAGATCCAGGTGCCCTCCAACTTAGCCCTGAAATTTGCTGATGCCCACAACA 
R E Q IQVPSNLALKFADAHNM 
TGCTCTTGTTTGAGACATCGGCCAAGGACCCCAAAGAGAG~~AGAACGTGGAGTCGATTT 
L LFETSAKD PKESQNVESIF 
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TCATGTGCTTGGCTTGCCGATTGAAGGCCCAGGCCCAGAAAT~CCTGCTGTATCG~rGATGCTGAGA 1080 
M C L A C R 1, K A Q KSLLYRDAER 
GGCAGCAGGGGAAGGTGCAGAAACTGGAGTTCCCACAGGAAGCTAACAGTAAAACTTCCT 1140 
Q Q G K VQKLEFP QEANSKTSC 
GTCCTTGTTGAAACCAAACGATATAAATACAAGATAAATTATCACTGGAGTTTTTTCTTT 1200 
P c * 
CCCTTTTTTCTGTGCCTGCATAATGCTGACACCTGCTTGTTTCCATACAAATTGATATCA 1260 
A~T~~TTTGTATAGATTATCAAA~AAAAA 1293 
Fig. 1. Nucleottde sequence and deduced amino acid sequence of SlO cDNA. The cDNA sequence was estabhshed by the combmatlon of tao 
overlappmg cDNA clones, SIO-32 (nucleotldes 1 to 1171) and SIO-4 (nucleotldes 533 to 1293). SlO-4 had C residue at posmon 742, whtch results 
in ammo acid subslltution of T m place of M. This variation can be an artifact in cDNA clonmg or may represent tNo alleles present m Jurkat 
cells. G-l through G-5 reglonn conserved m small GTP-bmding proteins are underlmed. 
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insert DNA of SlO PCR clone. Two positive clones were 
isolated, subcloned in a plasmid vector, and sequenced. 
These two clones overlapped with each other compris- 
ing the sequence of 1,293 nucleotides. As shown in Fig. 
1, the sequence had an open reading frame of 711 bp 
which can encode a protein of 237 amino acids. The 
translation start site was compatible with the consensus 
sequence of Kozak [16], but the first methionine codon 
at nucleotide 438 was not preceded by any stop codon, 
leaving the possibility that the open reading frame starts 
from more S-region beyond the end of the isolated 
cDNA. However, this possibility is unlikely for the fol- 
lowing reasons. First, the size of the cDNA was almost 
the same as the size of transcript (1.3 kb) detected by 
Northern hybridization. And second, the 5’-region of 
cloned cDNA contained CA repeat sequences unlikely 
to encode a functional peptide. 
The deduced amino acid sequence of SlO had all 
characteristics of the small GTP-binding proteins. The 
regions G-l to G-5 were conserved and C-terminal cys- 
teine residues susceptible to isoprenoid modification 
were present. SlO had highest homology to yeast YPTl 
protein with 40% identity and 78% similarity. Human 
rabl had 39% identity and 72% similarity. Table I lists 
the percent identity of the guanine nucleotide binding 
domain [ 171 between small GTP-binding proteins. Per- 
cent identity of SlO in this region were 3447% with 
members of rab subfamily, and 2432% with other 
small GTP-binding proteins (Table I and data not 
shown). From these data, we conclude that SlO belongs 
to rab subfamily. As rab family proteins function in 
vesicular transport, SlO protein may also play a role in 
the transport system. 
3.3. E.upression of SlO in human cell lines 
In order to determine the cell type specific expression 
of S 10, Northern blot hybridization were performed on 
RNA extracted from various human tumor cell lines 
(Fig. 2). Expression of SlO was detected in cell lines of 
Table I 
SlO Homology to small GTP-bmdmg proteins 
SlO rabl rab3 rab3A rab4 rab5 rab6 H-ras rhoA TC4 
SIO 47 38 37 36 40 37 32 ‘5 31 
rab 1 _ 50 52 46 47 41 37 29 32 
rab2 ~ 42 60 42 40 35 31 30 
rab3A 38 37 42 31 29 29 
rab4 ~ 42 39 33 29 33 
rab5 - 45 33 28 33 
rab6 31 32 28 
H-ras 31 26 
rhoA 27 
TC4 
The values represent the percentage of amino acid identity wrthin the 
guanine nucleotide bmdmg domain, corresponding to ammo actds 5 
to 164 of H-ras protem [17]. Human sequences were used for calcula- 
tion. 
_ SIO 
(1.3kb) 
- /3-actin 
Fig. 2. Northern hybridrzation with SlO cDNA probe. Twentypg each 
of total RNA from human cell lines was electrophoresed, transferred, 
and hybridized wtth SlO cDNA probe as descrrbed m section 2. After 
removal of the probe. the same membrane was rehybrrdtzed with a 
j?-actm probe. 
T lymphocyte (Jurkat, CEM, and MOLT4) and B lym- 
phocyte (RPM11788 and EBV523). A histiocytic leuke- 
mia cell line (U937) also expressed SIO mRNA, al- 
though we could not detect transcription in other mon- 
ocytic cell lines (THP-1 and Jill), in a myelo-mon- 
ocytic cell line (HL60) (data not shown), or in a myelo- 
cytic leukemia cell line (K563). SlO was not expressed 
in cell lines on non-hematopoietic origin: retinoblas- 
toma (Y79), neuroblastoma (IMR32). glioblastoma 
(T98G). adrenal cortex adenoma (SW13). terato- 
carcinoma (NCC-IT). hepatoma (HepG2), stomach 
cancer (AZ52 1). epidermoid carcinoma (A43 I), fibro- 
sarcoma (HTI 080). and cervical carcinoma (HeLa) 
(Fig. 2 and data not shown). 
Restriction of expression to lymphoid and monocytic 
lineage may suggest the function of SlO specific to these 
cells. rab3A [18,19] and rab15 [20] are expressed only 
in neural tissues and rab3A was proposed to play a role 
in synaptic vehicle release being consistent with the ex- 
pression pattern [9]. rac2 is predominantly expressed in 
lymphoid and myelo-monocytic cells [21l23] and was 
implicated to control superoxide production [ 10.1 11. 
Expression pattern of SlO was similar to that of rac2. 
However, SlO was expressed only in U937 cells among 
the cell lines of myelo-monocytic lineage tested, and the 
expression diminished after differentiation of U937 with 
dibutyryl cyclic AMP (data not shown) in contrast to 
the augmentation of rac2 expression [21]. Moreover, 
rac2 is also expressed in HeLa cells [21] and MDCK 
kidney cells [24]. Thus expression of SlO appears to be 
more restricted than rac2. Further investigation is re- 
quired to elucidate the function of SlO in lymphoid and 
monocytic cells. 
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